We harness AI to accelerate drug discovery
Accutar Biotech is a U.S.-based company. We use artificial intelligence (AI) technology to explain the physical and chemical nature of biological systems.
What is our philosophy?
Drug Discovery Pipeline
AI Approach and Solutions
Learn More
News
Accutar Biotechnology Receives FDA Fast Track Designation for AC699 in ER+ / HER2- Breast Cancer
Aug 14, 2024
Read More
Accutar Biotechnology Presents Phase 1 Data of AC699 Monotherapy in Patients with ER+ / HER2- Breast Cancer at ASCO 2024
Jun 01, 2024
Read More
Evommune and Accutar Biotechnology Announce AI Drug Discovery Collaboration
Nov 28, 2023
Read More